Article
Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR.
Genes, chromosomes & cancer - 1 Jan 2004
Pandita Ajay, Aldape Kenneth D, Zadeh Gelareh, Guha Abhijit, James C David
Abstract excerpt
Despite the high incidence of EGFR amplification in patient glioblastoma multiforme (GBM) tissues, only a single GBM cell line, of the many described in the literature, is known to contain and maintain amplified EGFR. Because EGFR mutations in GBM manifest primarily, if not exclusively, in amplified form, it follows that the availability of cell lines with mutation of endogenous EGFR would also be in short...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
